CALL - SPRINTER OPEN END - MERCK & CO. | Delayed Deutsche Boerse AG 04:22:45 2024-06-13 am EDT | ||
| 3.77 EUR | -1.57% |
|
| Current month | +15.36% | ||
| 1 month | -1.03% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-13 | 3.77 | -1.57% |
| 24-06-12 | 3.83 | -2.30% |
| 24-06-11 | 3.92 | +1.55% |
| 24-06-10 | 3.86 | +1.05% |
| 24-06-07 | 3.82 | +2.96% |
Delayed Quote Deutsche Boerse AG
Last update June 13, 2024 at 04:22 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Vontobel
|
| WKN | VM542U |
| ISIN | DE000VM542U9 |
| Date issued | 2023-11-29 |
| Strike | 89.92 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.32 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.1 € |
|---|---|
| Lowest since issue | 1.36 € |
| Spread | 0.08 € |
| Spread % | 2.07% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.2
USD
Average target price
142.7
USD
Spread / Average Target
+9.59%
- Stock Market
- Certificates
- Certificat
